In this research, animal and cellular models of NAFLD were constructed to verify whether Foxa2 attenuates NAFLD progression by modulating the NF-κB/IKK pathway. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.